List of Kyorin Pharmaceutical patents

Patents where

Current Assignee

Name

‌

Kyorin Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 6937940 Method of superposing molecular structures of compounds	Patent 6937940 was granted and assigned to Kyorin Pharmaceutical on August, 2005 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	6937940	August 30, 2005
‌ US Patent 7902367 Cyclic amino benzoic acid derivative	Patent 7902367 was granted and assigned to Kyorin Pharmaceutical on March, 2011 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7902367	March 8, 2011
‌ US Patent 7351429 Oral solid preparation	Patent 7351429 was granted and assigned to Kyorin Pharmaceutical on April, 2008 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7351429	April 1, 2008
‌ US Patent 7781617 Effective use method of medicaments and method of preventing expression of side effect	Patent 7781617 was granted and assigned to Kyorin Pharmaceutical on August, 2010 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7781617	August 24, 2010
‌ US Patent 7361783 (2S)-2-ethylphenylpropionic acid derivative	Patent 7361783 was granted and assigned to Kyorin Pharmaceutical on April, 2008 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7361783	April 22, 2008
‌ US Patent 7049342 Substituted phenylpropionic acid derivatives	Patent 7049342 was granted and assigned to Kyorin Pharmaceutical on May, 2006 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7049342	May 23, 2006
‌ US Patent 7560569 Bicycloamide derivative	Patent 7560569 was granted and assigned to Kyorin Pharmaceutical on July, 2009 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7560569	July 14, 2009
‌ US Patent 9603804 Solid pharmaceutical composition	Patent 9603804 was granted and assigned to Kyorin Pharmaceutical on March, 2017 by the United States Patent and Trademark Office.	‌ Kyorin Pharmaceutical	‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	9603804	March 28, 2017
‌ US Patent 10029983 Urea derivative or pharmacologically acceptable salt thereof	Patent 10029983 was granted and assigned to Kyorin Pharmaceutical on July, 2018 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	10029983	July 24, 2018
‌ US Patent 9687453 Solid pharmaceutical composition	Patent 9687453 was granted and assigned to Kyorin Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.	‌ Kyorin Pharmaceutical	‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	9687453	June 27, 2017
‌ US Patent 7763617 Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient	Patent 7763617 was granted and assigned to Kyorin Pharmaceutical on July, 2010 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7763617	July 27, 2010
‌ US Patent 7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant	Patent 7482491 was granted and assigned to Kyorin Pharmaceutical on January, 2009 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7482491	January 27, 2009
‌ US Patent 11326163 Therapeutic agent for fibrosis		‌ Kyorin Pharmaceutical	‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	11326163	May 10, 2022
‌ US Patent 7514451 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative	Patent 7514451 was granted and assigned to Kyorin Pharmaceutical on April, 2009 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7514451	April 7, 2009
‌ US Patent 6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant	Patent 6960692 was granted and assigned to Kyorin Pharmaceutical on November, 2005 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	6960692	November 1, 2005
‌ US Patent 7456157 Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators	Patent 7456157 was granted and assigned to Kyorin Pharmaceutical on November, 2008 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7456157	November 25, 2008
‌ US Patent 8404710 Phosphodiesterase 10A inhibitor	Patent 8404710 was granted and assigned to Kyorin Pharmaceutical on March, 2013 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	8404710	March 26, 2013
‌ US Patent 8476261 Spirocyclic aminoquinolones as GSK-3 inhibitors	Patent 8476261 was granted and assigned to Kyorin Pharmaceutical on July, 2013 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	8476261	July 2, 2013
‌ US Patent 8063221 Aminoquinolones as GSK-3 inhibitors	Patent 8063221 was granted and assigned to Kyorin Pharmaceutical on November, 2011 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	8063221	November 22, 2011
‌ US Patent 11261155 Urea derivative or pharmacologically acceptable salt thereof	Patent 11261155 was granted and assigned to Kyorin Pharmaceutical on March, 2022 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	11261155	March 1, 2022
‌ US Patent 8222407 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position	Patent 8222407 was granted and assigned to Kyorin Pharmaceutical on July, 2012 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	8222407	July 17, 2012
‌ US Patent 8232319 Amino phosphate derivative and S1P receptor modulator having same as an active ingredient	Patent 8232319 was granted and assigned to Kyorin Pharmaceutical on July, 2012 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	8232319	July 31, 2012
‌ US Patent 10406149 Aqueous liquid formulation	Patent 10406149 was granted and assigned to Kyorin Pharmaceutical on September, 2019 by the United States Patent and Trademark Office.	‌ Kyorin Pharmaceutical	‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	10406149	September 10, 2019
‌ US Patent 7879846 Serine hydrolase inhibitors	Patent 7879846 was granted and assigned to Kyorin Pharmaceutical on February, 2011 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7879846	February 1, 2011
‌ US Patent 7754757 Bicycloester derivative	Patent 7754757 was granted and assigned to Kyorin Pharmaceutical on July, 2010 by the United States Patent and Trademark Office.		‌ Kyorin Pharmaceutical	United States Patent and Trademark Office	7754757	July 13, 2010

Results per page:

81 results

0 selected

81 results

0 selected